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Abstract: Background:
Limited data are available on long-term mortality and morbidity of patients with chronic obstructive 
pulmonary disease (COPD) and ischemic heart disease. We examined how COPD affects the long-
term mortality and morbidity after undergoing percutaneous coronary intervention (PCI) and 
coronary artery bypass grafting (CABG).
Methods:
We analyzed 9877 consecutive patients who underwent their first elective PCI (n = 6878) and 
CABG (n = 2999) in 2000-2002 at 30 institutions listed in the CREDO-Kyoto registry. 
Results: 
COPD was diagnosed in 240 patients (2.4%). In-hospital mortality (1.3% vs. 1.2%, p = 0.972) did 
not differ between patients with and without COPD. During long-term follow up (42.8 months), 906 
patients (9.4%) died, 517 (5.3%) of whom died of cardiovascular death and 376 (3.9%), of cardiac 
death. At 3 years, the unadjusted survival rate and the rates of freedom from cardiovascular death 
and cardiac death were 92.1%, 95.3%, and 96.5% in the total population and 82.8%, 91.7%, and 
92.1% in patients with COPD respectively. Log-rank test indicated that COPD was associated with 
higher incidence of all-cause mortality (p < 0.0001), cardiovascular death (p = 0.0002), and cardiac 
death (p < 0.0001). Multivariate analyses indicated that COPD was an independent predictor of all-
cause mortality (hazard ratio 1.36, p = 0.0003), cardiovascular death (hazard ratio 1.28, p = 
0.0407), and cardiac death (hazard ratio 1.48, p = 0.003). 
Conclusions:
COPD is an independent risk factor for long-term cardiac and cardiovascular mortality in patients 
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Structured abstract (Word count = 248)
Background:
Limited data are available on long-term mortality and morbidity of patients with chronic 
obstructive pulmonary disease (COPD) and ischemic heart disease. We examined how 
COPD affects the long-term mortality and morbidity after undergoing percutaneous 
coronary intervention (PCI) and coronary artery bypass grafting (CABG).
Methods:
We analyzed 9877 consecutive patients who underwent their first elective PCI (n = 
6878) and CABG (n = 2999) in 2000–2002 at 30 institutions listed in the 
CREDO-Kyoto registry. 
Results: 
COPD was diagnosed in 240 patients (2.4%). In-hospital mortality (1.3% vs. 1.2%, p = 
0.972) did not differ between patients with and without COPD. During long-term follow 
up (42.8 months), 906 patients (9.4%) died, 517 (5.3%) of whom died of cardiovascular 
death and 376 (3.9%), of cardiac death. At 3 years, the unadjusted survival rate and the 
rates of freedom from cardiovascular death and cardiac death were 92.1%, 95.3%, and 
96.5% in the total population and 82.8%, 91.7%, and 92.1% in patients with COPD 



































































all-cause mortality (p < 0.0001), cardiovascular death (p = 0.0002), and cardiac death (p 
< 0.0001). Multivariate analyses indicated that COPD was an independent predictor of 
all-cause mortality (hazard ratio 1.36, p = 0.0003), cardiovascular death (hazard ratio 
1.28, p = 0.0407), and cardiac death (hazard ratio 1.48, p = 0.003). 
Conclusions:
COPD is an independent risk factor for long-term cardiac and cardiovascular mortality 





































































Chronic obstructive pulmonary disease (COPD) is a common comorbidity 
among patients undergoing percutaneous coronary intervention (PCI) and coronary 
artery bypass grafting (CABG) 1-3. Although some cohort studies have revealed that 
patients with COPD have a significantly higher risk of in-hospital mortality and 
long-term all-cause mortality following PCI and CABG 4-14, the effects of COPD on 
long-term mortality and morbidity in patients with ischemic heart disease have not been 
adequately demonstrated. To examine these effects, we evaluated the long-term 





































































The Coronary Revascularization Demonstrating Outcome Study in Kyoto 
(CREDO-Kyoto) registry has collected data on the potential risk factors and outcomes 
in 9877 consecutive patients who underwent their first elective PCI (n = 6878) and 
CABG (n = 2999) at the 30 institutions between 2000 and 2002 in Japan. Patients with 
acute myocardial infarction within 1 week prior to the index procedure were excluded. 
The relevant review boards or ethics committees in all 30 participating centers 
(Appendix A) approved the research protocol. A description of the design and study 
protocol has been previously published15 and the study protocol is concordant with the 
guidelines for epidemiologic studies issued by the Ministry of Health, Labor and Welfare 
of Japan. In order to examine whether COPD is an independent predictor of all-cause 
mortality, cardiovascular death, and cardiac death following PCI and CABG, we 
performed post hoc analysis of the data collected from 9756 consecutive patients who 
survived their first elective PCI (n = 6846) and CABG (n = 2910). The primary end 
point was all-cause mortality, cardiovascular death, and cardiac death. Demographic and 
angiographic characteristics before coronary intervention, and procedural data were 
collected from hospital charts or databases in each center by independent clinical 



































































registry include patient demographics (e.g., age and gender), potential risk factors, and 
comorbidities (e.g., COPD, stroke, hypertension, and current smoking status) that have 
been demonstrated to be related to short-term and long-term outcomes.
All procedural decisions, including the technique of revascularization and 
device selection, were made at the discretion of the patient, the physician, and the 
surgeon performing PCI and CABG.
Definition
A patient was considered to have COPD if it was listed as a comorbid condition 
in our database and its diagnosis was confirmed by a simple test called spirometry, 
which measures how deeply a person can breathe and how fast air can move into and 
out of his or her lungs. Such a diagnosis should be considered in any patient who has 
symptoms of cough, sputum production, or dyspnea (difficult or labored breathing), 
and/or a history of exposure to risk factors for the disease. In cases where spirometry is 
unavailable, the diagnosis of COPD should be made using all available tools. Clinical 
symptoms and signs such as abnormal shortness of breath and increased forced 
expiratory time can be used to arrive at the diagnosis. A low peak flow is consistent with 



































































performance during testing. Chronic cough and sputum production often precede the 
development of airflow limitation by many years, although not all individuals with 
cough and sputum production go on to develop COPD. Congestive heart failure was 
diagnosed on the basis of clinical signs (New York Heart Association [NYHA] > II). 
Diabetes or hypertension was considered to be present if the patients were previously 
diagnosed by another physician or if they were being treated with either insulin or oral 
antidiabetic drugs, or antihypertensive drugs respectively. Patients were considered to 
have a history of myocardial infarction if previously diagnosed by electrocardiogram or 
coronary angiography. The criteria for the diagnosis of periprocedural myocardial 
infarction were the appearance of new Q waves and an increase in creatine kinase to 
≥2.0 times the upper limit of normal occurring ≤24 hours after PCI. Stroke at the 
baseline included asymptomatic stroke detected by non-invasive imaging modalities. 
Peripheral vascular disease was considered to be present when patients were being 
treated for carotid, aortic, and/or other peripheral vascular diseases or were scheduled 
for surgical or endovascular interventions. Left ventricular ejection fraction was 
measured either by contrast left ventriculography or echocardiography. Patients with left 
ventricular ejection fraction < 40% were deemed to have left ventricular dysfunction. 



































































Cockroft-Gault formula was less than 60 mL/min. Anemia was defined as blood 
hemoglobin level < 12 g/dL.
Long-term follow up was performed using outpatient visits and chart review. A 
central adjudication committee reviewed all deaths in a blinded fashion by using source 
documentation provided by the site investigators.
Statistical analysis 
Standard descriptive statistics (proportions and 2 tests) were used to list patient 
and disease characteristics by subgroup. Statistical analysis of categorical variables was 
carried out using cross tables with the Pearson χ2 test. Survival curves were estimated 
using the Kaplan-Meier method and compared with the log-rank statistics. To determine 
the baseline risk factors for the incidence of all-cause mortality, cardiovascular death, 
and cardiac death, we developed Cox proportional hazards models for the following 24 
potential variables: COPD, the technique of revascularization, gender, body mass index, 
emergency procedure, prior myocardial infarction, congestive heart failure, stroke, 
peripheral artery disease, chronic atrial fibrillation, malignancy, hypertension, diabetes 
without insulin therapy, diabetes with insulin therapy, dialysis, chronic renal disease, 



































































the coronary artery, proximal left anterior descending coronary artery disease, left main 
coronary artery disease, age, and triple vessel disease. All continuous variables were 
dichotomized so as to agree with the proportional assumptions according to the 
predetermined clinical contexts. We plotted log (time) vs. log[–log (survival)] stratified 
by each significant risk factor and evaluated whether the plotted lines were parallel16. 
The variables for which p values were less than 0.05 in univariate analyses and 
proportional assumptions were generally fair were included in the multivariate analyses. 
We developed multivariate Cox proportional hazards models that controlled for 
significant risk factors while testing for significant differences in long-term results. The 
appropriateness of the proportional hazards assumption for these variables has been 
attested elsewhere (Kimura manuscript). All analyses were performed with JUMP 




































































COPD was diagnosed in 240 patients (2.4%) on the basis of the baseline 
characteristics, which are shown in Table 1. Patients with COPD were more likely to 
have congestive heart failure, stroke, peripheral artery disease, chronic renal disease, 
anemia, and left ventricular dysfunction. They also tended to be older and had a lower 
average body mass index. Patients without COPD were more likely to be women and 
having diabetes that did not require insulin therapy. No difference was detected in the 
current smoking status in the 2 groups.
In-hospital mortality (1.3% vs. 1.2%, p = 0.9724) and in-hospital Q-wave 
myocardial infarction incidence (0.8% vs. 0.9%, p = 0.8572) did not differ between the 
groups (Table 2). 
A total of 98% and 95% patients continued to attend follow-up examinations at 
the end of 1 and 2 years respectively. During long-term follow up (median follow-up 
period = 42.8 months), 906 patients (9.4%) died, 517 (5.3%) of which died of 
cardiovascular death and 376 (3.9%), of cardiac death. Of the total population, 265 
patients (2.7%) suffered acute myocardial infarction, and 468 (4.8%) suffered stroke. Of 
the patients with COPD, 50 (21.3%) died, of which 24 (10.3%) died of cardiovascular 



































































myocardial infarction, and 11 (4.7%) suffered stroke. At 3 years, the unadjusted survival 
rate and the rates of freedom from cardiovascular death and cardiac death were 92.1%, 
95.3%, and 96.5% in the total population and 82.8%, 91.7%, and 92.1% in patients with 
COPD, respectively. 
Univarate analysis revealed that COPD was associated with higher all-cause 
mortality (p < 0.0001), cardiovascular death (p = 0.0002), and cardiac death (p < 
0.0001); Kaplan-Meier survival curves are presented in Figure 1. 
Multivariate analyses (considering the baseline characteristics and the results of 
univariate analyses) indicated that COPD was an independent predictor of all-cause 




































































Smoking as a risk factor is common to both COPD and ischemic heart disease; 
hence, these 2 diseases often coexist 17, 18. Previous studies have shown that patients 
with COPD have a significantly higher risk of long-term all-cause mortality after PCI 
and CABG 5-14. The manner in which COPD affects long-term mortality and morbidity 
in patients with ischemic heart disease remains unresolved. We analyzed 9877 
consecutive patients who underwent their first elective PCI (n = 6878) and CABG (n = 
2999) at 30 institutions in Japan. Univariate and multivariate analyses in this study 
indicated that COPD was an independent predictor of all-cause mortality. To our 
knowledge, this study is the first to show that patients with COPD have a significantly 
higher risk of cardiac and cardiovascular death following PCI and CABG. 
The manner in which COPD affects the incidence of long-term adverse cardiac 
events after coronary revascularization is not quite clear. It was reported that patients 
affected by COPD have an increased risk of acute atherothrombotic events, and that this 
increase is independent of smoking and other cardiovascular risk factors. Further, 
bronchial inflammation reportedly spreads to the systemic circulation and is known to 
play a key role in plaque formation and rupture 19. While the current smoking status did 



































































with COPD were more likely to have peripheral artery disease and stroke as 
pre-operative comorbidities. Exacerbation of COPD may overtax an already diseased 
heart because of hypoxemia and increased work of breathing. It was reported that severe 
hypoxemia can worsen cardiac ischemia in patients with ischemic heart disease 20, 21. On 
the other hand, exacerbation of ischemic heart disease can further impair gas exchange 
by incrementally increasing airway resistance or reducing mixed venous 
oxyhemoglobin saturation. Cardiac arrhythmias are frequent among patients with 
COPD. Previous studies reported widely various incidence of arrhythmia and 
arrhythmia related death in patients with COPD and it was reported that about ten 
percent of patients with COPD suffer from SCD22-26. However, the role of serious 
ventricular arrhythmias in these situations is unknown27. An association between severe 
COPD and increased QTc dispersion was reported, which has been reported as a marker 
of ventricular electrical instability28. It is not clear whether treating asymptomatic 
ventricular arrhythmia can reduce the incidence of SCD or not in patients with 
COPD22-26 . This study demonstrated that COPD was associated with a higher incidence 
of long-term cardiac and cardiovascular mortality and morbidity. However additional 
interventional therapy for COPD was not recorded in our database, and so further study 



































































mortality and morbidity from cardiac causes in patients with ischemic heart disease.
Though it was reported that the severity of COPD might affect in-hospital 
outocomes after PCI and CABG, we found that patients with COPD undergoing elective 
PCI and CABG had in-hospital morbidity and mortality rates comparable with those of 
controls after first elective PCI and CABG in this study. Previously it was demonstrated 
that post-CABG mortality was largely higher in patients with severe COPD receiving 
steroids than that of patients without COPD, however post-CABG mortality of patients 
with mild or moderate COPD was similar to that of patients without COPD4, 5 . 
However the severity of COPD was not well examined because pulmonary function test 
was not recorded in our database, and so further study may be needed to investigate the 
relationship between severity of COPD and short- and long-term mortality in patients 
with ischemic heart disease.
This study has some limitations. The definition of COPD in our study was 
consistent with that in many other studies 1, 2, 9-11, and 240 patients with COPD were 
identified in our study, which accounted for 2.4% of total population. However, the 
definition of COPD might be slightly lenient because the results of pulmonary function 
tests were not recorded in our database. Because ventricular function was evaluated 



































































some patients with left ventricle dysfunction with a concomitant decrease in the risk of 
all-cause mortality and cardiac death. In this study, we found that after the first elective 
PCI and CABG, the in-hospital morbidity rates in patients with COPD and control were 
comparable. It has been reported that the severity of COPD might affect in-hospital 
outcomes after PCI and CABG 4, 5; however, the severity of COPD was not adequately 
determined in our study because the results of pulmonary function tests were not 
recorded in our database. Moreover, we have no information regarding the adjunctive 
pharmacotherapy after discharge and the duration of some of these comorbidities; these 




































































We are indebted to the clinical research coordinators for data collection and to 
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Unadjusted Kaplan-Meier Event-free Survival Curves for All-cause Mortality (Panel A), 
Cardiovascular death (Panel B), and Cardiac Death (Panel C).




































































Appendix A. List of participating centers and investigators
Centers Investigators
Fukuroi Municipal Hospital Katsuo Okazaki
Hamamatsu Rosai Hospital Masaaki Takahashi
Teiji Oda
Hikone Municipal Hospital Shigeo Matsui
Naohiro Ohashi
Himeji Medical Center Eiichi Matsuyama
Makoto Kadoya
Hyogo Prefectural Amagasaki Hospital Yoshiki Takatsu
Shinichi Nomoto
Kazuaki Kataoka
Japanese Red Cross Society, Wakayama Medical Center Hajime Kotoura
Masaki Aota
Akira Miura
Juntendo University Shizuoka Hospital Satoru Suwa






































































Kansai Denryoku Hospital Takeshi Aoyama
Takahiro Sakurai
Kishiwada City Hospital Mitsuo Matsuda
Masahiko Onoe
Yuzo Takeuchi
Kitano Hospital Ryuji Nohara
Kimisato Nakano










































































Koto Memorial Hospital Tomoyuki Murakami
Katsuya Ishida




Kurashiki Central Hospital Kazuaki Mitsudo 
Tatsuhiko Komiya
Kazushige Kadota
Kyoto University Hospital Takeshi Kimura 
Masashi Komeda
Maizuru Kyosai Hospital Ryozo Tatami
Teruaki Ushijima





































































Nara Hospital, Kinki University School of Medicine Ryuichi Hattori 
Noboru Nishiwaki
Manabu Shirotani
Nishi-Kobe Medical Center Hiroshi Kato
Hiroshi Eizawa
Osaka Red Cross Hospital Masaru Tanaka 
Kazuaki Minami




Shimabara Hospital Mamoru Takahashi 
Takafumi Tahata 
Yoshiki Matoba




































































Shizuoka City Shizuoka Hospital Akinori Takizawa 
Mitsuomi Shimamoto
Fumio Yamazaki





Takanohara Central Hospital Masaki Kawanami






































































Appendix B. List of clinical research coordinators
Kumiko Kitagawa, Hiromi Yoshida, Misato Yamauchi, Asuka Saeki, Chikako Hibi, Emi 
Takinami, Izumi Miki, Miya Hanazawa, Naoko Okamoto, Sachiko Maeda, Saeko 
Minematsu, Saori Tezuka, Yuki Sato, Yumika Fujino, Hitomi Sasae, Rei Fujita, Ayu 
Motofusa, Takami Hiraoka, Ayumi Yamamoto, Miho Hayashikawa, and Yoko Fujiki
A.J.S. Coats , MD
Editor-in-Chief: INTERNATIONAL JOURNAL OF CARDIOLOGY
October, 2008
Dear Professor A.J.S. Coats:
        Please find our manuscript entitled “Chronic Obstructive Pulmonary 
Disease—an Independent Risk Factor for Long-term Cardiac and Cardiovascular 
Mortality in Patients with Ischemic Heart Disease” by Kei Nishiyama et al., which we 
would like to submit for publication as original research papers. Chronic obstructive 
pulmonary disease (COPD) and ischemic heart disease (IHD) share smoking as a risk 
factor, so these two diseases often coexist. Previous studies have shown patients with 
COPD have a significantly higher risk of long-term all-cause mortality after having PCI 
and CABG. This study also demonstrated patients with COPD also have higher 
long-term mortality rates than those without COPD after first elective PCI and CABG. 
The question of how having COPD affect long-term mortality and morbidity in patients 
with ischemic heart disease remains unsettled. To our knowledge, this study is the first 
Cover Letter
report showing patients with COPD have a significantly higher risk of cardiac death and 
cardiovascular death after having PCI and CABG.
  The manuscript has not been published and is not being considered for 
publication elsewhere in whole or part in any language. All authors have read and 
approved the manuscript. No conflict of interests exists in any of the authors in this 
study. 
Your kind consideration would be greatly appreciated. 
Yours sincerely,
Kei Nishiyama, MD
Department of Cardiovascular Medicine,







Click here to download high resolution image
p-value
n % n %
Having PCI 166 69.2% 6709 69.7% 0.8715
Female gender 42 17.5% 2855 29.6% <0.0001
Emergency procedure 12 5.0% 532 5.4% 0.7212
Proir myocardial infarction 71 29.7% 2476 25.7% 0.1730
Congestive heart failure 51 21.3% 1216 12.7% 0.0003
Stroke 54 22.5% 1587 16.5% 0.0177
Peripheral artery disease 38 15.8% 1101 11.4% 0.0447
Chronic atrial fibrillation 20 8.3% 653 6.8% 0.5787
Malignancy 23 9.6% 680 7.1% 0.1523
Hypertension 150 62.5% 6657 69.2% 0.0303
Diabetes without insulin therapy 59 24.6% 2957 30.7% 0.0491
Diabetes with insulin therapy 17 7.1% 223 8.3% 0.4770
Dialysis 5 2.1% 402 4.2% 0.0769
Chronc kidney disease 137 58.8% 3775 40.4% <0.0001
Anemia 77 32.5% 2458 26.1% 0.0320
Current smoker status 105 43.8% 3375 35.7% 0.5340
Left ventricular dysfunction 31 14.2% 708 8.1% 0.0031
Chronic total occulusion of coronary artery 80 33.3% 2941 30.5% 0.3759
Proximal left anterior descending coronary artery disease 171 71.3% 6916 71.8% 0.8453
Left main coronary artery disease 22 9.2% 933 9.7% 0.7851
Triple vessel disease 80 33.3% 3123 31.6% 0.7691
p-value
Age <0.0001
Body mass index <0.0001
(n=240) (n=9632)
COPD = chronic obstructive pulmonary disease; PCI = percutaneous coronary intervention.
Table 1. Patient and Disease Characteristics
COPD
Yes No
21.7 ± 3.7 23.7 ± 3.2





Clinical Outcomes HR 95% CI p-value HR 95% CI p-value
All-Cause mortality (n=906) 1.60 1.38-1.83 <0.0001 1.36 1.16-1.57 0.0003
Cardiac death (n=376) 1.65 1.31-2.02 0.0002 1.45 1.14-1.81 0.004
Not-adjusted Adujusted
Table 3. Cox Proportional-Hazards Model for All-cause Mortality and Cardiac Death 
HR = hazard ratio; CI = confidential index.
Table 3
Clinical Outcomes
In-hospital death 3 1.3% 118 1.2% 0.9724
In-hospital QMI 2 0.8% 91 0.9% 0.8572
MACE 7 2.9% 235 2.4% 0.6464
Hospitalization (days) 0.0034
(n=9632)
COPD = chronic obstructive pulmonary disease; QMI = Q-wave 
myocardial infarction; MACE = major adverse cardiac event.
Table 2. In-hospital Outcomes
22.6±29.6 18.1±21.7
p-value
COPD
Yes No
(n=240)
Table 2
